Imidazoline receptors: A challenge

Pharmaceutica Acta Helvetiae

Volumn 74, Issue 2-3, 2000, Pages 205-209

  Bousquet, Pascal ^a   Bruban, Véronique ^a   Schann, Stephan ^a   Feldman, Josiane ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

2 adrenoceptors; Blood pressure; Imidazoline; Imidazoline receptors

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; APRACLONIDINE; IDAZOXAN; IMIDAZOLINE RECEPTOR; LNP 509; METIZOLINE; RECEPTOR SUBTYPE; S 23515; S 23757; UNCLASSIFIED DRUG;

ANIMAL TISSUE; BINDING AFFINITY; BLOOD PRESSURE; BRAIN STEM; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; HYPOTENSION; NONHUMAN;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BINDING SITES; HUMANS; IMIDAZOLES; LIGANDS; RECEPTORS, DRUG;

EID: 0034080805     PISSN: 00316865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-6865(99)00051-5     Document Type: Conference Paper

References (44)

1. Atlas D., Burstein Y. Isolation of an endogenous clonidine-displacing substance from rat brain. FEBS Lett. 170:1984;387-390.
2. Atlas D., Burstein Y. Isolation and partial purification of a clonidine displacing endogenous brain substance. Eur. J. Biochem. 144:1984;287-293.
3. Bennai F., Greney H., Stutzmann J., Bousquet P., Dontenwill M. Development of anti-idiotypic antibodies specific for the human cerebral imidazoline receptor. Ann. N. Y. Acad. Sci. 763:1995;140-148.
4. Bousquet P. Recent advances in imidazoline receptor research. Exp. Opin. Invest. Drugs. 4(5):1995;431-442.
5. Bousquet P. Imidazoline receptors. Neurochem. Int. 30:1997;3-7.
6. Bousquet P., Feldman J., Schwartz J. Central cardiovascular effects of α-adrenergic drugs: difference between catecholamines and imidazolines. J. Pharmacol. Exp. Ther. 230:1984;230-236.
7. Bousquet P., Feldman J., Atlas D. An endogenous, non-catecholamine clonidine antagonist increases mean arterial blood pressure. Eur. J. Pharmacol. 124:1986;167-170.
8. Bousquet P., Greney H., Bennai F., Feldman J., Stutzmann J., Belcourt A., Dontenwill M. Imidazoline receptors and cardiovascular regulations: a statement. Ann. N. Y. Acad. Sci. 763:1995;526-530.
9. 2-adrenoceptors in the central hypotensive effects of imidazoline-like drugs. Ann. N. Y. Acad. Sci. 881:1999;272-278.
10. Brasili L., Pigini M., Bousquet P., Carotti A., Dontenwill M., Giannella M., Moriconi R., Piergentili A., Quaglia W., Tayebati S.K. Discovery of highly selective imidazoline receptor ligands. Perspective in Receptor Research. 24:1996;361-376.
11. Bricca G., Dontenwill M., Molines A., Feldman J., Belcourt A., Bousquet P. Evidence for the existence of a homogenous population of imidazoline receptors in the human brainstem. Eur. J. Pharmacol. 150:1988;401-402.
12. Bricca G., Dontenwill M., Molines A., Feldman J., Tibiriça E., Belcourt A., Bousquet P. Rilmenidine selectivity for imidazoline receptors in human brain. Eur. J. Pharmacol. 163:1989;373-377.
13. 3H ]idazoxan in the human cerebral cortex J. Neurochem. Int. 2:1993;153-163.
14. 3H ]clonidine Eur. J. Pharmacol., Mol. Pharmacol. Sect. 266:1994;25-33.
15. Coupry I., Podevin R.A., Dausse J.P., Parini A. Evidence for imidazoline binding sites in basolateral membranes from rabbit kidney. Biochem. Biophys. Res. Commun. 147:1987;1055-1060.
16. 2-adrenoceptors in the ventrolateral medulla. Eur. J. Pharmacol. 134:1987;113.
17. Ernsberger P.R., Meeley M.P., Reis D.J. An endogenous substance with clonidine like properties: selective binding to imidazole sites in the ventrolateral medulla. Brain Res. 441:1988;309-318.
18. Ernsberger P., Giuliano R., Willette R.N., Reis D.J. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostro-ventrolateral medulla. J. Pharmacol. Exp. Ther. 253:1990;408-418.
19. 1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease. J. Hypertens. 15(suppl):1997;S9-S23.
20. Escriba P.V., Sastre M., Wang H., Regunathan S., Reis D.J., Garcia-Sevilla J.A. Immunodetection of putative imidazoline receptor proteins in the human and rat brain and other tissues. Neurosci. Lett. 178:1994;81-84.
21. Feldman J., Tibiriça E., Bricca G., Dontenwill M., Belcourt A., Bousquet P. Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit. Br. J. Pharmacol. 100:1990;600-604.
22. Greney H., Bennai F., Molines A., Belcourt A., Dontenwill M., Bousquet P. Isolation of a human cerebral imidazoline-specific binding protein. Eur. J. Pharmacol. 265:1994;R1-R2.
23. Head G.A. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents. Ann. N. Y. Acad. Sci. 763:1995;531-540.
24. Head G.A., Godwin S.J., Sannajust F. Differential receptors involved in the cardiovascular effects of clonidine and rilmenidine in conscious rabbits. J. Hypertens. 11(5):1993;S322-S325. Suppl.
25. Heemskerk F.M.J., Dontenwill M., Greney H., Vonthron C., Bousquet P. Evidence for the existence of imidazoline specific binding sites in synaptosomal plasma membranes of the bovine brainstem. J. Neurochem. 71:1998;2193-2202.
26. 2-adrenoceptors in rabbit adipocyte membranes Eur. J. Pharmacol. 159:1989;199-203.
27. Lepran I., Papp J.P. Effect of moxonidine on arrhythmias induced by coronary artery occlusion and reperfusion. J. Cardiovasc. Pharmacol. 24(1):1994;S9-S15. Suppl.
28. Li G., Regunathan S., Barrow C.J., Eshraghi J., Cooper R., Reis D.J. Agmatine: an endogenous clonidine displacing substance in the brain. Science. 263:1994;966-969.
29. Limon I., Coupry I., Lanier S.M., Parini A. Purification and characterisation of mitochondrial imidazoline-guanidinium receptive site from rabbit kidney. J. Biol. Chem. 267:1992;21645-21649.
30. 2A-adrenergic receptor subtype. Science. 273:1996;801-803.
31. Mammoto T., Kamabayashi T., Hayashi Y., Yamatodani A., Takada K., Yoshiya I. Antiarrhythmic of rilmenidine on adrenaline-induced arrhythmia via central imidazoline receptors in halothane anaesthetized dogs. Br. J. Pharmacol. 117:1996;1744-1748.
32. Meeley M.P., Ernsberger P.R., Granata A.R., Reis D.J. An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla. Life Sci. 38:1986;1119-1126.
33. 1-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs. Ann. N. Y. Acad. Sci. 763:1995;620-633.
34. Molderings G.J., Hentrich F., Göthert M. Pharmacological characterisation of the imidazoline receptor which mediates inhibition of noradrenaline release in the rabbit pulmonary artery. Naunyn-Schmiedberg's Arch. Pharmacol. 344:1991;630-638.
35. Molderings G.J. Imidazoline receptors: basic knowledge, recent advances and future prospects for therapy and diagnostic. Drug of the Future. 22(7):1997;757-772.
36. 2-adrenergic receptor. J. Biol. Chem. 264:1989;11874-11878.
37. Piletz J.E., Sletten K. Nonadrenergic imidazoline binding sites on human platelets. J. Pharmacol. Exp. Ther. 267:1993;1493-1502.
38. Regunathan S., Reis D.J. Imidazoline receptors and their endogenous ligands. Annu. Rev. Pharmacol. Toxicol. 36:1996;511-544.
39. Roegel J.C., Yannoulis N., De Jong W., Monassier L., Feldman J., Bousquet P. Inhibition of centrally-induced ventricular arrhythmias by rilmenidine and idazoxan in rabbits. Naunyn-Schmiedeberg's Arch. Pharmacol. 354:1996;598-605.
40. 1-imidazoline receptors to diacylglyceride accumulation in PC12 rat pheochromocytoma cells. Mol. Pharmacol. 49:1996;668-675.
41. Sun M.K., Regunathan S., Reis D.J. Cardiovascular responses to agmatine, a clonidine displacing substance, in anaesthetized rats. Clin. Exp. Hypertens. 17:1995;115-128.
42. Verbeuren T.J., Dinh Xuan A.T., Koenig-Bérard E., Vitou P. Rilmenidine. Cardiovasc. Drug Rev. 8:1990;56-70.
43. Wang H., Regunathan S., Meeley M.P., Reis D.J. Isolation and characterisation of imidazoline receptor protein from bovine adrenal chromaffin cells. Mol. Pharmacol. 42:1992;792-801.
44. Wikberg J.E.S. High affinity binding of idazoxan to a non-catecholaminergic binding site in the central nervous system: description of a putative idazoxan-receptor. Pharmacology and Toxicology. 64:1989;152-155.